[Clinical observation of the treatment of infantile viral myocarditis with puerarin].
OBJECTIVE
To observe the clinical effect of the treatment of infantile viral myocarditis with puerarin.


METHODS
Puerarin was administered intravenously together with conventional treatment in the treated group, while that of conventional treatment solely was given in the control group. Creatine kinase isoenzyme, lactate dehydrogenase isoenzyme, cardiac function and clinical manifestations before and after treatment were observed.


RESULTS
Puerarin could significantly relieve the symptoms of patients of infantile viral myocarditis, enhance the metabolism of myocardium and improve the cardiac function. The total effective rate of the treated group was 87.04%, significantly higher than that of the control group, the difference between them was significant (P < 0.05).


CONCLUSIONS
Puerarin can be used to treat patients with infantile viral myocarditis with a satisfactory result.
Meng
P
P
Union Hospital of Tongji Medical University, Wuhan (430022).
Zhou
D
D
Hu
X
X
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003402:Creatine Kinase / Q000378:metabolism; D005260:Female; D006801:Humans; D007223:Infant; D007262:Infusions, Intravenous; D007527:Isoenzymes / Q000378:metabolism; D007529:Isoflavones / Q000627:therapeutic use*; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008297:Male; D009205:Myocarditis / Q000188:drug therapy* / Q000821:virology*
D000319:Adrenergic beta-Antagonists; D007527:Isoenzymes; D007529:Isoflavones; D007770:L-Lactate Dehydrogenase; D003402:Creatine Kinase; C033607:puerarin